Literature DB >> 33985953

Leptomeningeal Enhancement Due to COVID-19 on 3D-FLAIR and T1 Black-Blood MR Imaging Sequences.

G Velonakis1, E Karavasilis1, D K Filippiadis1, M P Almyroudi1, E Korompoki1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 33985953      PMCID： PMC8324286          DOI： 10.3174/ajnr.A7104

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN： 0195-6108            Impact factor:   4.966


× No keyword cloud information.
  4 in total

Review 1.  MRI Brain Findings in 126 Patients with COVID-19: Initial Observations from a Descriptive Literature Review.

Authors:  E Gulko; M L Oleksk; W Gomes; S Ali; H Mehta; P Overby; F Al-Mufti; A Rozenshtein
Journal:  AJNR Am J Neuroradiol       Date:  2020-09-03       Impact factor: 3.825

2.  Application of 3D Fast Spin-Echo T1 Black-Blood Imaging in the Diagnosis and Prognostic Prediction of Patients with Leptomeningeal Carcinomatosis.

Authors:  J Oh; S H Choi; E Lee; D J Shin; S W Jo; R-E Yoo; K M Kang; T J Yun; J-H Kim; C-H Sohn
Journal:  AJNR Am J Neuroradiol       Date:  2018-07-12       Impact factor: 3.825

Review 3.  Use of Magnetic Resonance Imaging to Visualize Leptomeningeal Inflammation in Patients With Multiple Sclerosis: A Review.

Authors:  Jonathan Zurawski; Hans Lassmann; Rohit Bakshi
Journal:  JAMA Neurol       Date:  2017-01-01       Impact factor: 18.302

4.  Neurologic Features in Severe SARS-CoV-2 Infection.

Authors:  Julie Helms; Stéphane Kremer; Hamid Merdji; Raphaël Clere-Jehl; Malika Schenck; Christine Kummerlen; Olivier Collange; Clotilde Boulay; Samira Fafi-Kremer; Mickaël Ohana; Mathieu Anheim; Ferhat Meziani
Journal:  N Engl J Med       Date:  2020-04-15       Impact factor: 91.245
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.